NUVA — NuVasive Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareBalancedMid Cap

Annual cashflow statement for NuVasive, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2018 December 31st	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	12.5	65.2	-37.2	-64.1	40.4
Depreciation
Deferred Taxes
Non-Cash Items	97.7	80.4	151	150	55.4
Unusual Items
Purchased R&D
Other Non-Cash Items
Changes in Working Capital	-9.33	-51.8	-51.4	-49.3	-62.7
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Accrued Expenses
Change in Payable / Accrued Expenses
Change in Taxes Payable
Change in Other Liabilities
Cash from Operating Activities	219	235	186	182	169
Capital Expenditures	-110	-130	-110	-112	-139
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	-51.7	-4.1	-172	-23.6	-15.8
Acquisition of Business
Sale/Maturity of Investment
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities	-161	-134	-282	-136	-155
Financing Cash Flow Items	-19.8	1.42	-8.79	-1.33	-8.73
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	-14.6	-6.64	737	-653	-8.59
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	42	94.3	644	-611	2.57